A Study of BLB-201 RSV Vaccine in Infants and Children

NCT05655182 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

137

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Syncytial Virus Infections

Interventions

BIOLOGICAL: PIV5-vectored RSV Vaccine (BLB-201) Low Dose
BIOLOGICAL: PIV5-vectored RSV Vaccine (BLB-201) High Dose
DRUG: Placebo

Sponsor

Blue Lake Biotechnology Inc.